Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.51 |
| ▸ | PKM | P14618 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | MME | P08473 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 2/20 | 0.36 |
| ▸ | POLB | P06746 | 3/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.33 |
| ▸ | PPM1B | O75688 | 1/20 | 0.33 |
| ▸ | GLA | P06280 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.33 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.33 |
| ▸ | APEX1 | P27695 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethylene Glycol SCHEMBL4564907 | 1.00 | ALDH1A1 (0.51) | ALDH1A1PKMKMT2AATMMME | |
| Ethylene Glycol SCHEMBL3259443 | 1.00 | ALDH1A1 (0.51) | ALDH1A1PKMKMT2AATMMME | |
| SCHEMBL30302184 | 0.94 | ALDH1A1 (0.53) | ALDH1A1PKMKMT2AATMMME | |
| SCHEMBL604671 | 0.94 | ALDH1A1 (0.56) | ALDH1A1PKMKMT2AATMMME | |
| SCHEMBL2332165 | 0.94 | ALDH1A1 (0.56) | ALDH1A1PKMKMT2AATMMME | |
| Thioglycolic Acid SCHEMBL27759668 | 0.93 | ALDH1A1 (0.46) | ALDH1A1PKMKMT2AATMMME | |
| Ethylene SCHEMBL8387032 | 0.91 | ALDH1A1 (0.53) | ALDH1A1PKMKMT2AATMMME | |
| Ethylene SCHEMBL29141463 | 0.91 | ALDH1A1 (0.53) | ALDH1A1PKMKMT2AATMMME | |
| Ethylene Glycol SCHEMBL9329904 | 0.91 | ALDH1A1 (0.44) | ALDH1A1PKMKMT2AATMMME | |
| Propionic Acid SCHEMBL7866660 | 0.87 | ALDH1A1 (0.50) | ALDH1A1PKMKMT2AATMMME |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3138 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122081456-A | Plant chromatin conformation capturing method and kit | — | 2026-05-26 | — | — | CN | claimed |
| EP-4719485-A1 | ANTIBODY-DRUG CONJUGATES FOR TREATING INFECTIONS OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) | Taimed Biologics Inc. (TW) | 2026-04-08 | — | — | EP | claimed |
| EP-4716755-A1 | RNA PROBING AND AMPLIFICATION METHODS FOR SINGLE CELL ANALYSIS ON FIXED CELLS | Becton, Dickinson and Company (US) | 2026-04-01 | — | — | EP | claimed |
| EP-4689130-A2 | METHODS AND COMPOSITIONS FOR ENHANCED EXPRESSION OF EXOGENOUS CASEINS IN TRANSGENIC PLANTS | Mozza Foods Inc. (US) | 2026-02-11 | — | — | EP | claimed |
| US-20260002849-A1 | SEQUENTIAL CROSSLINKING WITH HYDROPHOBIC AND HYDROPHILIC CHEMICAL CROSSLINKERS FOR SAMPLE PRESERVATION | 10X GENOMICS, INC. (US) | 2026-01-01 | — | — | US | claimed |
| US-12467088-B2 | Probe-based analysis of nucleic acids and proteins | 10X GENOMICS, INC. (US) | 2025-11-11 | — | — | US | claimed |
| EP-4642491-A1 | METHOD FOR GLYCOPROTEIN MODIFICATION | Honeybear Biosciences Inc. (TW) | 2025-11-05 | — | — | EP | claimed |
| WO-2025226837-A1 | ANTI-BACTERIAL METALLOTHIONEIN ANTIBODIES AND USES THEREOF | UNIVERSITY OF CONNECTICUT (US) | 2025-10-30 | — | — | WO | claimed |
| US-12449419-B1 | Methods for detecting binding of peptide-MHC monomers to T cells | 10X GENOMICS, INC. (US) | 2025-10-21 | — | — | US | claimed |
| US-20250295745-A1 | CROSS-LINKED TUMOR LYSATE SPHERICAL NUCLEIC ACIDS AS CANCER VACCINES | NORTHWESTERN UNIVERSITY | 2025-09-25 | — | — | US | claimed |
| EP-1090637-A2 | Compositions and methods for treating or preventing inflammatory diseases | Angiotech Pharmaceuticals, Inc. (CA) | 2001-04-11 | — | — | EP | claimed |
| JP-2001503785-A | — | — | 2001-03-21 | — | — | JP | claimed |
| EP-1070502-A2 | Compositions and methods for treating or preventing inflammatory diseases | Angiotech Pharmaceuticals, Inc. (CA) | 2001-01-24 | — | — | EP | claimed |
| EP-1042003-A1 | DELIVERY OF LONG LASTING THERAPEUTIC AGENTS BY FORMING COVALENT ATTACHMENTS IN VIVO | Conjuchem, Inc. (CA) | 2000-10-11 | — | — | EP | claimed |
| WO-1999062510-A2 | COMPOSITIONS COMPRISING ANTI-MICROTUBULE AGENTS FOR TREATING OR PREVENTING INFLAMMATORY DISEASES | ANGIOTECH PHARMACEUTICALS, INC. (CA) | 1999-12-09 | — | — | WO | claimed |
| WO-1999048536-A2 | DELIVERY OF LONG LASTING THERAPEUTIC AGENTS BY FORMING COVALENT ATTACHMENTS IN VIVO | CONJUCHEM, INC. (CA) | 1999-09-30 | — | — | WO | claimed |
| EP-0941089-A2 | COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING INFLAMMATORY DISEASES | Angiotech Pharmaceuticals, Inc. (CA) | 1999-09-15 | — | — | EP | claimed |
| WO-1998024427-A2 | COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING INFLAMMATORY DISEASES | ANGIOTECH PHARMACEUTICALS, INC. (CA) | 1998-06-11 | — | — | WO | claimed |
| US-4665089-A | IMIDOESTER OR N-HYDROXYSUCCINIMIDE ESTER | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1987-05-12 | — | — | US | claimed |
| EP-0199103-A2 | Process for preventing or reversing cataract formation using protein modification reagents | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1986-10-29 | — | — | EP | claimed |